GLP-3 – 60mg
$900.00
GLP-3 60mg
Researchers are studying GLP-3, a synthetic peptide, for its potential applications in metabolic health. Furthermore, scientists are investigating its potential application in obesity, metabolic disorders, and diabetes, offering research to weight management and glucose control.
Potential Research Applications
GLP-3 is currently being explored in research settings for its role in:
- Obesity Treatment: Investigated for its potential to help manage and reduce body weight by regulating appetite, food intake, and metabolic rate.
- Blood Sugar Regulation: Researched for its ability to enhance insulin sensitivity, providing support in the management of blood sugar levels and potentially offering a solution for type 2 diabetes and prediabetes.
- Metabolic Health: Studied for its potential to improve overall metabolic function, supporting fat metabolism, energy balance, and lipid regulation.
- Weight Loss: Explored for its effects on stimulating fat loss and supporting weight management, making it a key compound in obesity research.
- GLP-1 Receptor Agonist Research: Investigated as part of a growing class of GLP-1 receptor agonists, which are being studied for their roles in regulating metabolic processes and promoting cardiovascular health.
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
GLP-3 is a synthetic peptide studied for its role in metabolism and weight management research. It acts as a dual receptor agonist for GIP and GLP-1. Researchers focus on its effects on glucose control, insulin sensitivity, and appetite regulation. This work is key for obesity and type 2 diabetes research.
GLP-3 activates both GIP and GLP-1 receptors. For example, GLP-1 helps release insulin, cuts appetite, and slows stomach emptying. In contrast, GIP aids insulin release and fat breakdown. Therefore, targeting both receptors may improve glucose balance and reduce food intake.
Early studies show that GLP-3 may promote weight loss. Its dual action likely may lower appetite, boost fullness, and aid energy balance. In addition, it may enhance insulin release and sensitivity.
GLP-3 also affects appetite and insulin sensitivity. Researchers study its use in obesity-related conditions such as fatty liver disease and heart disease. By improving fat metabolism and insulin sensitivity, it may lower risk factors.
Although early research shows promise, further studies must assess its long-term safety and effectiveness.
For Research Use Only.
No Certificate of Analysis images available for this product.
